CLEAN : France faces new health scandal over epilepsy drug

The transcript discusses studies on the effects of Depaquin on women and pregnancies, highlighting the lack of precise data on children with disabilities. It mentions the global distribution of Depaquin and the potential for similar scandals in other countries. The French Ministry of Health has acknowledged responsibility and committed to compensating victims, while the laboratory denies responsibility and is uncooperative with victims.

Quels pays sont mentionnés comme ayant potentiellement les mêmes effets secondaires de la dépaquine?

Quelles sont les difficultés rencontrées par les familles des victimes de la dépaquine?